Affinity prediction for substrates of the peptide transporter PepT1

被引：23
|
作者：
Bailey, PD
Boyd, CAR
Collier, ID
George, JP
Kellett, GL
Meredith, D
Morgan, KM
Pettecrew, R
Price, RA
机构：
[1] Univ Manchester, Sch Chem, Manchester M60 1QD, Lancs, England
[2] Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England
[3] Heriot Watt Univ, Sch EPS Chem, Edinburgh EH14 4AS, Midlothian, Scotland
[4] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England
来源：
CHEMICAL COMMUNICATIONS | 2006年 / 03期
关键词：
D O I：
10.1039/b511996k
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
A quantitative method has been developed for determining the affinity of substrates for the peptide transporter PepT1, allowing oral availability of drugs via PepT1 to be estimated.
引用
收藏
页码：323 / 325
页数：3
相关论文
共 50 条
  • [31] Regulation of human peptide transporter 1 (PEPT1) in gastric cancer cells by anticancer drugs
    Inoue, M
    Terada, T
    Okuda, M
    Inui, K
    CANCER LETTERS, 2005, 230 (01) : 72 - 80
  • [32] A cyclosporine derivative is a substrate of the oligopeptide transporter PepT1
    Foley, David W.
    Bermudez, Isabel
    Bailey, Patrick D.
    Meredith, David
    MEDCHEMCOMM, 2016, 7 (05) : 999 - 1002
  • [33] Conformational and spacial preferences for substrates of PepT1
    Bailey, PD
    Boyd, CAR
    Collier, ID
    George, JG
    Kellett, GL
    Meredith, D
    Morgan, KM
    Pettecrew, R
    Price, RA
    Pritchard, RG
    CHEMICAL COMMUNICATIONS, 2005, (42) : 5352 - 5354
  • [34] Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1
    Brodin, B
    Nielsen, CU
    Steffansen, B
    Frokjær, S
    PHARMACOLOGY & TOXICOLOGY, 2002, 90 (06): : 285 - 296
  • [35] Functional and structural characterization of a prokaryotic peptide transporter with features similar to mammalian PEPT1
    Weitz, Dietmar
    Harder, Daniel
    Casagrande, Fabio
    Fotiadis, Dimitrios
    Obrdlik, Petr
    Kelety, Bela
    Daniel, Hannelore
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (05) : 2832 - 2839
  • [36] Role of the Intestinal Peptide Transporter PEPT1 in Oseltamivir Absorption: In Vitro and In Vivo Studies
    Poirier, Agnes
    Belli, Sara
    Funk, Christoph
    Otteneder, Michael B.
    Portmann, Renee
    Heinig, Katja
    Prinssen, Eric
    Lazic, Stanley E.
    Rayner, Craig R.
    Hoffmann, Gerhard
    Singer, Thomas
    Smith, David E.
    Schuler, Franz
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (08) : 1556 - 1565
  • [37] Glycans in the intestinal peptide transporter PEPT1 contribute to function and protect from proteolysis
    Stelzl, Tamara
    Kerstin, E.
    Geillinger-Kaestle
    Stolz, Juergen
    Daniel, Hannelore
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2017, 312 (06): : G580 - G591
  • [38] How to make drugs orally active: A substrate template for peptide transporter PepT1
    Bailey, Patrick D.
    Boyd, C. A. Richard
    Bronk, J. Ramsey
    Collier, Ian D.
    Meredith, David
    Morgan, Keith M.
    Temple, Catherine S.
    Angewandte Chemie (International Edition in English), 2000, 39 (03): : 506 - 508
  • [39] Development and Characterization of a Novel Mouse Line Humanized for the Intestinal Peptide Transporter PEPT1
    Hu, Yongjun
    Xie, Yehua
    Wang, Yuqing
    Chen, Xiaomei
    Smith, David E.
    MOLECULAR PHARMACEUTICS, 2014, 11 (10) : 3737 - 3746
  • [40] A novel high-throughput PepT1 transporter assay differentiates between substrates and antagonists
    Faria, Teresa N.
    Timoszyk, Julita K.
    Stouch, Terry R.
    Vig, Balvinder S.
    Landowski, Christopher P.
    Amidon, Gordon L.
    Weaver, C. David
    Wall, Doris A.
    Smith, Ronald L.
    MOLECULAR PHARMACEUTICS, 2004, 1 (01) : 67 - 76
12345